GSI Technology, Inc. reported third‑quarter fiscal 2026 revenue of $6.1 million, a 12% year‑over‑year increase from $5.4 million in Q3 2025 but a 4% sequential decline from $6.4 million in Q2 2026. The decline is largely attributable to a shift toward lower‑margin SRAM and APU products, which made up a larger share of the revenue mix this quarter.
Gross margin fell to 52.7% from 54.8% in the prior quarter and from 54.0% in the same quarter a year earlier. The compression reflects the product‑mix shift and the higher cost of raw materials for the newer, higher‑performance chips that are still in the early stages of commercialization.
Operating expenses rose to $10.1 million, driven by a $7.5 million increase in research and development. The R&D spend supports the Gemini‑II and Plato roadmaps, with the company investing heavily in hardware and software development to accelerate market entry.
Operating loss narrowed to $(6.9) million from $(9.2) million a year ago, but the prior‑year loss was actually $(4.1) million. The improvement is largely due to higher revenue and a more favorable mix, offsetting the higher R&D outlay.
Net loss for the quarter was $3 million, or $0.09 per diluted share, compared with a $4 million net loss ($0.16 per diluted share) in Q3 2025. The lower loss represents a beat of $0.07 per share, driven by cost containment and a stronger mix of high‑margin products.
Management guided for Q4 fiscal 2026 net revenue of $5.7 million to $6.5 million and a gross margin of 54% to 56%. The guidance signals confidence that the company will recover sequentially and that the margin compression seen in Q3 will reverse as higher‑margin products gain traction.
Market reaction was mixed. Investors welcomed the company’s robust cash position of $70.7 million and the progress on Gemini‑II and government‑funded projects, but remained cautious about the ongoing margin erosion and operating losses that could pressure profitability.
Lee‑Lean Shu, CEO, said the quarter “demonstrated solid demand for our SRAM solutions and a clear path toward commercializing Gemini‑II in defense and edge‑AI markets.” Douglas Schirle, CFO, added that the company’s cash reserves “enable continued investment in R&D while maintaining financial flexibility.”
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.